# FDA Inspection 1243232 - South Charlotte VA HCC - June 27, 2024

Source: https://www.keypedia.com/records/fda_inspections/south-charlotte-va-hcc/a311fcad-324e-46e3-9415-a5940f44d69a
Source feed: FDA_Inspections

> FDA Inspection 1243232 for South Charlotte VA HCC on June 27, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1243232
- Company Name: South Charlotte VA HCC
- Inspection Date: 2024-06-27
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1177224 - 2022-07-27](https://www.keypedia.com/records/fda_inspections/south-charlotte-va-hcc/e794078e-0106-4cf9-ba6d-5e288c6d0fe9)
- [FDA Inspection 1177224 - 2022-07-27](https://www.keypedia.com/records/fda_inspections/south-charlotte-va-hcc/45e07cac-7fb4-46ef-b249-5dd9196c0f0d)

Company: https://www.keypedia.com/companies/south-charlotte-va-hcc/d8b12152-4c62-404a-9a0c-cd01473d8150

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d